Perbak Capital Partners LLP Sells 4,633 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Perbak Capital Partners LLP reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 80.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,115 shares of the healthcare conglomerate's stock after selling 4,633 shares during the period. Perbak Capital Partners LLP's holdings in UnitedHealth Group were worth $564,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Northern Trust Corp boosted its position in UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in UnitedHealth Group by 35.5% in the fourth quarter. The Manufacturers Life Insurance Company now owns 2,138,094 shares of the healthcare conglomerate's stock valued at $1,081,576,000 after purchasing an additional 560,607 shares in the last quarter. Optiver Holding B.V. acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $424,000. Bellwether Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at $65,000. Finally, Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on UNH shares. KeyCorp reduced their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Truist Financial lowered their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research note on Monday, April 21st. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Erste Group Bank upgraded UnitedHealth Group to a "strong-buy" rating in a research note on Wednesday, April 16th. Finally, Raymond James reiterated a "strong-buy" rating and set a $540.00 price target (down from $635.00) on shares of UnitedHealth Group in a report on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $603.05.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $420.04 on Tuesday. The company has a market capitalization of $382.33 billion, a price-to-earnings ratio of 27.10, a PEG ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $412.02 and a 52 week high of $630.73. The stock's 50-day simple moving average is $501.46 and its 200-day simple moving average is $532.94.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.00%. UnitedHealth Group's dividend payout ratio is currently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.